Literature DB >> 28589441

Ephrin ligands and Eph receptors contribution to hematopoiesis.

Giovanna Tosato1.   

Abstract

Hematopoietic stem and progenitor cells reside predominantly in the bone marrow. They supply billions of mature blood cells every day during life through maturation into multilineage progenitors and self-renewal. Newly produced mature cells serve to replenish the pool of circulating blood cells at the end of their life-span. These mature blood cells and a few hematopoietic progenitors normally exit the bone marrow through the sinusoidal vessels, a specialized venous vascular system that spreads throughout the bone marrow. Many signals regulate the coordinated mobilization of hematopoietic cells from the bone marrow to the circulation. In this review, we present recent advances on hematopoiesis and hematopoietic cell mobilization with a focus on the role of Ephrin ligands and their Eph receptors. These constitute a large family of transmembrane ligands and receptors that play critical roles in development and postnatally. New insights point to distinct roles of ephrin and Eph in different aspects of hematopoiesis.

Entities:  

Keywords:  Blood; CXCL12/SDF1/CXCR4; Cell-to-cell signaling; Differentiation; Lymphocytes; Myeloid cells; Neutrophils; Niches; Stromal cells

Mesh:

Substances:

Year:  2017        PMID: 28589441     DOI: 10.1007/s00018-017-2566-1

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  184 in total

1.  Spatial localization of transplanted hemopoietic stem cells: inferences for the localization of stem cell niches.

Authors:  S K Nilsson; H M Johnston; J A Coverdale
Journal:  Blood       Date:  2001-04-15       Impact factor: 22.113

Review 2.  Mechanisms of ephrin-Eph signalling in development, physiology and disease.

Authors:  Artur Kania; Rüdiger Klein
Journal:  Nat Rev Mol Cell Biol       Date:  2016-01-21       Impact factor: 94.444

Review 3.  The journey of developing hematopoietic stem cells.

Authors:  Hanna K A Mikkola; Stuart H Orkin
Journal:  Development       Date:  2006-10       Impact factor: 6.868

Review 4.  Essential roles of EphB receptors and EphrinB ligands in endothelial cell function and angiogenesis.

Authors:  Ombretta Salvucci; Giovanna Tosato
Journal:  Adv Cancer Res       Date:  2012       Impact factor: 6.242

Review 5.  Making sense of hematopoietic stem cell niches.

Authors:  Philip E Boulais; Paul S Frenette
Journal:  Blood       Date:  2015-03-11       Impact factor: 22.113

6.  Ephrin-B2 selectively marks arterial vessels and neovascularization sites in the adult, with expression in both endothelial and smooth-muscle cells.

Authors:  N W Gale; P Baluk; L Pan; M Kwan; J Holash; T M DeChiara; D M McDonald; G D Yancopoulos
Journal:  Dev Biol       Date:  2001-02-15       Impact factor: 3.582

7.  Sinusoidal ephrin receptor EPHB4 controls hematopoietic progenitor cell mobilization from bone marrow.

Authors:  Hyeongil Kwak; Ombretta Salvucci; Roberto Weigert; Jorge L Martinez-Torrecuadrada; Mark Henkemeyer; Michael G Poulos; Jason M Butler; Giovanna Tosato
Journal:  J Clin Invest       Date:  2016-11-07       Impact factor: 14.808

8.  Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4.

Authors:  H U Wang; Z F Chen; D J Anderson
Journal:  Cell       Date:  1998-05-29       Impact factor: 41.582

9.  Development of hematopoietic stem cell activity in the mouse embryo.

Authors:  A M Müller; A Medvinsky; J Strouboulis; F Grosveld; E Dzierzak
Journal:  Immunity       Date:  1994-07       Impact factor: 31.745

10.  EphB signaling directs peripheral nerve regeneration through Sox2-dependent Schwann cell sorting.

Authors:  Simona Parrinello; Ilaria Napoli; Sara Ribeiro; Patrick Wingfield Digby; Marina Fedorova; David B Parkinson; Robin D S Doddrell; Masanori Nakayama; Ralf H Adams; Alison C Lloyd
Journal:  Cell       Date:  2010-10-01       Impact factor: 41.582

View more
  6 in total

1.  Highly multiplexed proteomic assessment of human bone marrow in acute myeloid leukemia.

Authors:  Haydar Çelik; Katherine E Lindblad; Bogdan Popescu; Gege Gui; Meghali Goswami; Janet Valdez; Christin DeStefano; Catherine Lai; Julie Thompson; Jack Y Ghannam; Giovanna Fantoni; Angélique Biancotto; Julián Candia; Foo Cheung; Gauthaman Sukumar; Clifton L Dalgard; Richard H Smith; Andre Larochelle; Laura W Dillon; Christopher S Hourigan
Journal:  Blood Adv       Date:  2020-01-28

2.  Slc20a1b is essential for hematopoietic stem/progenitor cell expansion in zebrafish.

Authors:  Jiakui Chen; Gaofei Li; Junwei Lian; Ning Ma; Zhibin Huang; Jianchao Li; Zilong Wen; Wenqing Zhang; Yiyue Zhang
Journal:  Sci China Life Sci       Date:  2021-03-16       Impact factor: 6.038

3.  UniPR1331, a small molecule targeting Eph/ephrin interaction, prolongs survival in glioblastoma and potentiates the effect of antiangiogenic therapy in mice.

Authors:  Claudio Festuccia; Giovanni Luca Gravina; Carmine Giorgio; Andrea Mancini; Cristina Pellegrini; Alessandro Colapietro; Simona Delle Monache; Maria Giovanna Maturo; Roberta Sferra; Paola Chiodelli; Marco Rusnati; Annamaria Cantoni; Riccardo Castelli; Federica Vacondio; Alessio Lodola; Massimiliano Tognolini
Journal:  Oncotarget       Date:  2018-05-11

Review 4.  Harnessing the Power of Eph/ephrin Biosemiotics for Theranostic Applications.

Authors:  Robert M Hughes; Jitka A I Virag
Journal:  Pharmaceuticals (Basel)       Date:  2020-06-01

5.  Ephrin/Eph receptor interaction facilitates macrophage recognition of differentiating human erythroblasts.

Authors:  Lea A Hampton-O'Neil; Charlotte E Severn; Stephen J Cross; Sonam Gurung; Catherine D Nobes; Ashley M Toye
Journal:  Haematologica       Date:  2019-06-13       Impact factor: 9.941

6.  EphB1 interaction with caveolin-1 in endothelial cells modulates caveolae biogenesis.

Authors:  Chinnaswamy Tiruppathi; Sushil C Regmi; Dong-Mei Wang; Gary C H Mo; Peter T Toth; Stephen M Vogel; Radu V Stan; Mark Henkemeyer; Richard D Minshall; Jalees Rehman; Asrar B Malik
Journal:  Mol Biol Cell       Date:  2020-04-02       Impact factor: 4.138

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.